98 related articles for article (PubMed ID: 11279275)
1. Characterization of 'non-N-methyl-D-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures.
Hirbec H; Kamenka JM; Privat A; Vignon J
J Neurochem; 2001 Apr; 77(1):190-201. PubMed ID: 11279275
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
[TBL] [Abstract][Full Text] [Related]
3. Interaction of gacyclidine enantiomers with 'non-NMDA' binding sites in the rat central nervous system.
Hirbec H; Kamenka JM; Privat A; Vignon J
Brain Res; 2001 Mar; 894(2):189-92. PubMed ID: 11251192
[TBL] [Abstract][Full Text] [Related]
4. Binding properties of [3H]gacyclidine (cis(pip/me)-1-[1-(2-thienyl)-2-methylcyclohexyl]piperidine) enantiomers in the rat central nervous system.
Hirbec H; Teilhac J; Kamenka J; Privat A; Vignon J
Brain Res; 2000 Mar; 859(2):177-92. PubMed ID: 10719063
[TBL] [Abstract][Full Text] [Related]
5. Binding properties of [3H]gacyclidine in the rat central nervous system.
Hirbec H; Privat A; Vignon J
Eur J Pharmacol; 2000 Feb; 388(3):235-9. PubMed ID: 10675731
[TBL] [Abstract][Full Text] [Related]
6. Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.
Hirbec H; Gaviria M; Vignon J
CNS Drug Rev; 2001; 7(2):172-98. PubMed ID: 11474423
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of gacyclidine enantiomers in plasma and spinal cord after single enantiomer administration in rats.
Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Millart H; D'Arbigny P; Vistelle R
Int J Pharm; 2001 Oct; 229(1-2):147-53. PubMed ID: 11604267
[TBL] [Abstract][Full Text] [Related]
8. The novel non-competitive N-methyl-D-aspartate antagonist gacyclidine blocks the glutamate-induced release of hydroxyl radicals in the striatum under conditions in which dizocilpine does not. A microdialysis study in rats.
Laplanche L; Kamenka JM; Barbanel G
Neurosci Lett; 2000 Jul; 289(1):49-52. PubMed ID: 10899406
[TBL] [Abstract][Full Text] [Related]
9. Distribution of gacyclidine enantiomers in spinal cord extracellular fluid.
Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Lallemand A; D'Arbigny P; Millart H; Vistelle R
Pharm Res; 2000 Feb; 17(2):148-53. PubMed ID: 10751028
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury.
Feldblum S; Arnaud S; Simon M; Rabin O; D'Arbigny P
J Neurotrauma; 2000 Nov; 17(11):1079-93. PubMed ID: 11101210
[TBL] [Abstract][Full Text] [Related]
11. Modified gas chromatographic-mass spectrometric assay for the determination of gacyclidine enantiomers in human plasma.
Hoizey G; Baccard N; Gourdier B; Lamiable D; Millart H; D'Arbigny P; Vistelle R
J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):317-22. PubMed ID: 10510786
[TBL] [Abstract][Full Text] [Related]
12. Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.
Haradahira T; Okauchi T; Maeda J; Zhang MR; Nishikawa T; Konno R; Suzuki K; Suhara T
Synapse; 2003 Nov; 50(2):130-6. PubMed ID: 12923815
[TBL] [Abstract][Full Text] [Related]
13. Effects of the novel NMDA receptor antagonist gacyclidine on recovery from medial frontal cortex contusion injury in rats.
Smith JS; Fulop ZL; Levinsohn SA; Darrell RS; Stein DG
Neural Plast; 2000; 7(1-2):73-91. PubMed ID: 10709216
[TBL] [Abstract][Full Text] [Related]
14. Distribution of gacyclidine enantiomers after experimental spinal cord injury in rats: possible involvement of an active transport system.
Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Lallemand A; Millart H; D'Arbigny P; Vistelle R
J Pharm Sci; 2001 Jan; 90(1):70-8. PubMed ID: 11064380
[TBL] [Abstract][Full Text] [Related]
15. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity.
Berman FW; Murray TF
J Biochem Toxicol; 1996; 11(5):217-26. PubMed ID: 9110243
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: dose-window and time-window effects.
Gaviria M; Privat A; d'Arbigny P; Kamenka JM; Haton H; Ohanna F
J Neurotrauma; 2000 Jan; 17(1):19-30. PubMed ID: 10674755
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures.
Smith KJ; Self RL; Butler TR; Mullins MM; Ghayoumi L; Holley RC; Littleton JM; Prendergast MA
Brain Res; 2007 Jul; 1157():74-80. PubMed ID: 17524372
[TBL] [Abstract][Full Text] [Related]
19. The use of organotypic hippocampal slice cultures to evaluate protection by non-competitive NMDA receptor antagonists against excitotoxicity.
Ring A; Tanso R; Noraberg J
Altern Lab Anim; 2010 Mar; 38(1):71-82. PubMed ID: 20377305
[TBL] [Abstract][Full Text] [Related]
20. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman.
Lallement G; Baubichon D; Clarençon D; Galonnier M; Peoc'h M; Carpentier P
Neurotoxicology; 1999 Aug; 20(4):675-84. PubMed ID: 10499365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
